KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Amortizatization of Intangibles: 2019-2024

Historic Amortizatization of Intangibles for Arbutus Biopharma (ABUS) over the last 6 years, with Dec 2024 value amounting to $3.1 million.

  • Arbutus Biopharma's Amortizatization of Intangibles fell 44.96% to $541,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 0.67%. This contributed to the annual value of $3.1 million for FY2024, which is 42.76% up from last year.
  • According to the latest figures from FY2024, Arbutus Biopharma's Amortizatization of Intangibles is $3.1 million, which was up 42.76% from $2.2 million recorded in FY2023.
  • Over the past 5 years, Arbutus Biopharma's Amortizatization of Intangibles peaked at $3.1 million during FY2024, and registered a low of -$999,000 during FY2021.
  • In the last 3 years, Arbutus Biopharma's Amortizatization of Intangibles had a median value of $2.2 million in 2023 and averaged $1.8 million.
  • Per our database at Business Quant, Arbutus Biopharma's Amortizatization of Intangibles crashed by 375.71% in 2021 and then soared by 3,966.67% in 2023.
  • Arbutus Biopharma's Amortizatization of Intangibles (Yearly) stood at -$210,000 in 2020, then plummeted by 375.71% to -$999,000 in 2021, then soared by 105.41% to $54,000 in 2022, then surged by 3,966.67% to $2.2 million in 2023, then soared by 42.76% to $3.1 million in 2024.